TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Leo Pharma AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,516
|
34,613
|
40,313 |
Financial expenses |
27
|
93
|
62 |
Earnings before taxes |
1,599
|
1,421
|
510 |
Total assets |
26,194
|
23,344
|
21,977 |
Current assets |
26,192
|
23,341
|
21,972 |
Current liabilities |
14,398
|
12,102
|
11,279 |
Equity capital |
11,797
|
11,241
|
10,699 |
- share capital |
1,989
|
2,119
|
2,237 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.0%
|
48.2%
|
48.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.4%
|
4.1%
|
1.3% |
Return on assets (ROA) |
6.2%
|
6.5%
|
2.6% |
Current ratio |
181.9%
|
192.9%
|
194.8% |
Return on equity (ROE) |
13.6%
|
12.6%
|
4.8% |
Change turnover |
-2,970
|
-3,582
|
-15,117 |
Change turnover % |
-9%
![]() |
-9%
|
-27% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.